Table 2 Toxicity of the oxaliplatin-HDFL regimen

From: Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer

 

Patients (n=55)

Cycles (n=323)

 

Grade

Grade

Grade

Grade

Toxicity

1–2

3–4

1–2

3–4

Haematological

    

 Neutropenia

72.7a

21.8

34.3b

7.1

 Leukopenia

58.1

7.2

21.0

1.8

 Thrombocytopenia

60.0

12.7

24.5

5.0

 Febrile neutropenia

1.8

5.4

0.3

0.9

 Anaemia

61.8

9.0

34.7

2.8

Gastrointestinal

    

 Nausea

81.8

10.9

38.4

2.5

 Vomiting

87.2

12.7

31.6

2.2

 Diarrhoea

69.1

12.7

22.0

2.4

 Stomatitis

50.9

3.6

13.3

0.9

 Anorexia

70.9

1.8

36.5

0.3

 Weight loss

9.1

0

1.85

0

Neuropathic

72.7

12.7

46.8

2.2

Others

    

 Cardiac

0

1.8

0

0.3

 Fever

27.3

1.8

7.1

0.3

 Infection without neutropenia

16.4

0

4.3

0

 Alopecia

21.8

0

16.4

0

  1. aAll numbers are percentage of the 55 patients.
  2. bAll numbers are percentage of the 323 cycles given.